FDA Panel Agrees GSK’s RSV Vaccine Is Effective But Wants More Data Before Approval

 
• By Brenda Sandburg
  
RSV vaccine
Advisory committee votes in support of GSK's RSV vaccine for older adults but wants US FDA to delay approval • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers